N-Terminal Pro-Brain Natriuretic Peptide and Outcomes in Patients Undergoing Surgical Ventricular Restoration

American Journal of Cardiology

Volumn 105, Issue 5, 2010, Pages 640-644

  Ballotta, Andrea ^a   Ranucci, Marco ^a   Kunkl, Alessia ^a   El Baghdady, Hisham ^a   Bossone, Eduardo ^c   Castelvecchio, Serenella ^a,b   Frigiola, Alessandro ^b   Menicanti, Lorenzo ^b   Di Donato, Marisa ^b   Mehta, Rajendra H ^d  

^a Intensive Care Unit   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c Cardiology Unit   (Italy)

^d DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FORWARD HEART FAILURE; HEART EJECTION FRACTION; HEART LEFT VENTRICLE; HEART VENTRICLE REMODELING; HUMAN; MALE; MEDIASTINITIS; MORBIDITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REOPERATION; STROKE; TREATMENT OUTCOME;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; HEART VENTRICLES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME;

EID: 76849103371     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.047     Document Type: Article

References (15)

1. Schenk S., McCarthy P.M., Starling R.C., Hoercher K.J., Hail M.D., Ootaki Y., Francis G.S., Doi K., Young J.B., and Fukamachi K. Neurohormonal response to left ventricular reconstruction surgery in ischemic cardiomyopathy. J Thorac Cardiovasc Surg 128 (2004) 38-43
2. Suma H., Isomura T., Horii T., and Nomura F. Septal anterior ventricular exclusion procedure for idiopathic dilated cardiomyopathy. Ann Thorac Surg 82 (2006) 1344-1348
3. Sartipy U., Albage A., Larsson P.T., Insulander P., and Lindblom D. Changes in B-type natriuretic peptides after surgical ventricular restoration. Eur J Cardiothorac Surg 31 (2007) 922-928
4. Roques F., Nashef S.A., Michel P., Gauducheau E., de Vincentiis C., Baudet E., Cortina J., David M., Faichney A., Gabrielle F., Gams E., Harjula A., Jones M.T., Pintor P.P., Salamon R., and Thulin L. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 15 (1999) 816-822
5. Shahian D.M., O'Brien S.M., Filardo G., Ferraris V.A., Haan C.K., Rich J.B., Norman S.L.T., DeLong E.R., Shewan C.M., Dokholyan R.S., Peterson E.D., Edward F.H., and Anderson R.P. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 1-coronary artery bypass grafting surgery. Ann Thorac Surg 88 suppl (2009) S2-S22
6. Menicanti L., and Di Donato M. The Dor procedure: what has changed after fifteen years of clinical practice?. J Thorac Cardiovasc Surg 124 (2002) 886-890
7. Menicanti L., Castelvecchio S., Ranucci M., Frigiola A., Santambrogio C., de Vincentiis C., Brankovic J., and Di Donato M. Surgical therapy for ischemic heart failure: single-center experience with surgical anterior ventricular restoration. J Thorac Cardiovasc Surg 134 (2007) 433-441
8. de Lemos J.A., McGuire D.K., and Drazner M.H. B natriuretic peptide in cardiovascular disease. Lancet 362 (2003) 316-332
9. Maisel A.S., Krishnaswamy P., Nowak R.M., McCord J., Hollander J.E., Duc P., Omland T., Storrow A.B., Abraham W.T., Wu A.H., Clopton P., Steg P.G., Westheim A., Knudsen C.W., Perez A., Kazanegra R., Herrmann H.C., McCullough P.A., and Breathing Not Properly Multinational Study Investigators. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 347 (2002) 161-167
10. Tschöpe C., Kasner M., Westermann D., Gaub R., Poller W.C., and Schultheiss H.P. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 26 (2005) 2277-2284
11. de Lemos J.A., Morrow D.A., Bentley J.H., Omland T., Sabatine M.S., McCabe C.H., Hall C., Cannon C.P., and Braunwald E. The prognostic value of B-type natriuretic peptide in patients with acute coronary syndromes. N Engl J Med 345 (2001) 1014-1021
12. Yusoff R., Clayton N., Keevil B., Morris J., and Ray S. Utility of plasma N-terminal brain natriuretic peptide as a marker of functional capacity in patients with chronic severe mitral regurgitation. Am J Cardiol 97 (2006) 1498-1501
13. Bergler-Klein J., Mundigler G., Pibarot P., Burwash I.G., Dumesnil J.G., Blais C., Fuchs C., Mohty D., Beanlands R.S., Hachicha Z., Walter-Publig N., Rader F., and Baumgartner H. B-type natriuretic peptide in low-flow, low-gradient aortic stenosis: relationship to hemodynamics and clinical outcome: results from the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) study. Circulation 115 (2007) 2848-2855
14. Chello M., Mastroroberto P., Perticone F., Cirillo F., Bevacqua E., Olivito S., and Covino E. Plasma levels of atrial and brain natriuretic peptides as indicators of recovery of left ventricular systolic function after coronary artery bypass. Eur J Cardiothorac Surg 20 (2001) 140-146
15. Pina I.L., and O'Connor C. BNP-guided therapy for heart failure. JAMA 301 (2009) 432-434